Cargando…
A role for interleukin-1 receptor antagonism in severe COVID-19?
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352494/ https://www.ncbi.nlm.nih.gov/pubmed/34396155 http://dx.doi.org/10.1016/S2665-9913(21)00249-6 |
| _version_ | 1783736192460652544 |
|---|---|
| author | Tattersall, Rachel S McGonagle, Dennis Manson, Jessica J |
| author_facet | Tattersall, Rachel S McGonagle, Dennis Manson, Jessica J |
| author_sort | Tattersall, Rachel S |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8352494 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83524942021-08-10 A role for interleukin-1 receptor antagonism in severe COVID-19? Tattersall, Rachel S McGonagle, Dennis Manson, Jessica J Lancet Rheumatol Comment Published by Elsevier Ltd. 2021-10 2021-08-09 /pmc/articles/PMC8352494/ /pubmed/34396155 http://dx.doi.org/10.1016/S2665-9913(21)00249-6 Text en Crown Copyright © 2021 Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Comment Tattersall, Rachel S McGonagle, Dennis Manson, Jessica J A role for interleukin-1 receptor antagonism in severe COVID-19? |
| title | A role for interleukin-1 receptor antagonism in severe COVID-19? |
| title_full | A role for interleukin-1 receptor antagonism in severe COVID-19? |
| title_fullStr | A role for interleukin-1 receptor antagonism in severe COVID-19? |
| title_full_unstemmed | A role for interleukin-1 receptor antagonism in severe COVID-19? |
| title_short | A role for interleukin-1 receptor antagonism in severe COVID-19? |
| title_sort | role for interleukin-1 receptor antagonism in severe covid-19? |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352494/ https://www.ncbi.nlm.nih.gov/pubmed/34396155 http://dx.doi.org/10.1016/S2665-9913(21)00249-6 |
| work_keys_str_mv | AT tattersallrachels aroleforinterleukin1receptorantagonisminseverecovid19 AT mcgonagledennis aroleforinterleukin1receptorantagonisminseverecovid19 AT mansonjessicaj aroleforinterleukin1receptorantagonisminseverecovid19 AT tattersallrachels roleforinterleukin1receptorantagonisminseverecovid19 AT mcgonagledennis roleforinterleukin1receptorantagonisminseverecovid19 AT mansonjessicaj roleforinterleukin1receptorantagonisminseverecovid19 |